F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** THIS IS AN
EXAMPLE OF PAST NONCOMPLIANCE SUBSEQUENTLY CORRECTED PRIOR TO THIS SURVEY.
Residents Affected - Few
Based on medical record review, emergency room documentation review, review of the facility investigation,
interview, review of the Lantus (glargine) Insulin prescribing information, review of www.insulins.lilly.com the
facility failed to ensure medications were administered per physician orders resulting in a significant
medication error. This affected one resident (Resident #73) of three residents reviewed for medications.
Actual harm occurred on 03/14/25 at 10:30 P.M. when Resident #73, a diabetic resident who received
insulin with meals and at bedtime, was administered the incorrect type of insulin (short acting instead of
long-acting insulin) resulting in the resident having a headache, upset stomach and a blood sugar in low
range. The physician was notified and ordered an emergency department transfer. Resident #73 was
treated for hypoglycemia with intravenous fluids and concentrated intravenous dextrose before returning to
the facility.
Findings include:
Review of Resident #73's medical record revealed an admission date of 03/06/25 with diagnoses that
included diabetes mellitus, urinary tract infection with sepsis and hypertension.
Upon admission Resident #73 was ordered Humalog (rapid acting, mealtime insulin) six units
subcutaneously (SQ) with meals and insulin glargine (long-acting insulin) 54 units SQ at bedtime.
On 03/14/25 at 10:30 P.M. a progress note revealed Resident #73 was having a headache, upset stomach
and blood sugar in low range. The physician was updated on patient status and ordered to end to the
emergency department for evaluation. Resident #73 returned from the emergency department on 03/15/25
at 5:10 A.M. with no new orders.
Review of the facility transfer out of facility form completed on 03/14/25 revealed the indication for transfer
out was due to receiving the wrong medication.
Review of the emergency department Discharge summary dated [DATE] revealed Resident #73 was
diagnosed with hypoglycemia (low blood sugar) due to insulin and administered intravenous (IV) dextrose
5% in water one liter and dextrose 25 grams per 50 milliliters by IV twice.
A physician's progress note dated 03/15/25 indicated Resident #73 had an emergency department
evaluation after administered the incorrect dosage of Humalog.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
366214
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366214
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/10/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Canterbury Villa of Alliance
1785 Freshley Avenue
Alliance, OH 44601
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Actual harm
Residents Affected - Few
On 04/10/25 at 10:15 A.M. interview with the Director of Nursing confirmed Resident #73 was administered
54 units of Humalog instead of the ordered insulin glargine and was transferred to the emergency
department for evaluation and treatment per the physician.
Review of the facility investigation into the medication administration error revealed on 03/14/25 Resident
#73 was administered 54 units of Humalog instead of insulin glargine as ordered by the physician by
Licensed Practical Nurse (LPN) #91. A written statement by LPN #91 indicated that on 03/14/25 at 10:30
P.M. he administered the incorrect insulin to Resident #73.
On 04/10/25 at 12:08 P.M. telephone interview with LPN #91 verified that he administered 54 units of
Humalog insulin instead of the ordered insulin glargine to Resident #73 resulting in Resident #73 to be
transferred to the emergency department for evaluation and treatment with IV dextrose for low blood sugar.
During the interview the LPN stated the resident's blood sugar level was 75 (milliliters (ml) per deciliter (dL)
of blood); however, the resident's blood sugar level was not documented in the medical record and there
was limited information documented regarding the error.
Review of the Lantus (glargine) prescribing information revised June 2023 revealed Lantus (glargine) is a
long-acting insulin (works over an extended period of time). It is important to check insulin labels before
administration.
Review of the Humalog insulin patient information listed on www.insulins.lilly.com dated November 2023
revealed Humalog insulin is a rapid acting insulin that starts working faster and works for a shorter period of
time than a regular (short acting) insulin. It is identified as a mealtime insulin taken within 15 minutes before
or immediately after meals to help manage blood sugar levels after meals. Low blood sugar is a possible
serious side effect of Humalog insulin, and it can cause dizziness, lightheadedness, headache, blurred
vision, sweating, confusion, shakiness, fast heartbeat, anxiety, irritability, mood changes and hunger. Before
injecting each insulin dose, check the insulin label to make sure that you are taking the correct insulin.
Review of the facility policy Medication Administration dated 06/21/17 indicated that medication will be
administered by legally authorized and trained persons in accordance with State, Local and Federal laws
and consistent with accepted standards of practice.
The deficiency was corrected on 03/24/25 after the facility implemented the following corrective actions:
•
On 03/14/25 at 10:30 P.M. Resident #73 was assessed by Registered Nurse (RN) #95 for potential side
effects. The resident's skin was warm and dry. The resident was alert and oriented to person, place and
time.
•
On 03/14/25 Resident #73's physician was notified of the medication administration error and ordered to
send to the emergency department for evaluation and treatment.
•
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366214
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366214
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/10/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Canterbury Villa of Alliance
1785 Freshley Avenue
Alliance, OH 44601
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
On 03/14/25 the Director of Nursing was notified of the medication administration error.
Level of Harm - Actual harm
•
Residents Affected - Few
On 03/14/25 Resident #73 was transferred to the emergency department for evaluation and treatment and
returned on 03/15/25 with a diagnosis of hypoglycemia and treatment with IV dextrose.
•
On 03/15/25, Resident #73 received his scheduled insulin without incident.
•
On 03/19/25 LPN #91 completed online education for the following: Insulin Administration, Preventing
Medication Errors, Medication Awareness and Safe Handling of Medicines and Preparing and
Administering Insulin.
•
By 03/24/25 all 25 nurses received Insulin Administration education provided by the Director of Nursing via
handouts.
•
On 03/24/25 an ad-hoc (not scheduled) Quality Assurance Performance Improvement (QAPI) meeting was
held regarding the medication administration error. In-person attendees included the Administrator, DON,
Assistant Director of Nursing (ADON), and Minimum Data Set (MDS). The medical director attended via
phone.
•
Audits of insulin and medication administration were completed by nursing administration staff on 03/19/25,
03/20/25, 03/25/25, 03/28/25 and 04/02/25 with no evidence of administration errors. LPN #91 was audited
on 03/19/25 by Unit Manager #300.
•
There were no additional identified medication administration errors as of 04/10/25.
This deficiency represents non-compliance investigated under Master Complaint Number OH00164591 and
Complaint Numbers OH00164431 and OH00164415.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366214
If continuation sheet
Page 3 of 3